JOHNSON & JOHNSON
CIK 200406
13F filing for Q2 2026・No. 2,953
- Holdings
- US$798.65M
- Quarter change
- +US$146.29M
- Entries
- 15
- Net bought (estimate)
- +US$10.28M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 1
- Sold out 2
- Cut 0
- Added 0
- Corporate actions 0
- Unchanged 14
Largest holdings
15 stocks worth US$798.65M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| PTGXPROTAGONIST THERAPEUTICS INCCOM | Unchanged | 2,449,183 | US$300.22M | 37.59% |
| NANOBIOTIXSPONSORED ADS | Unchanged | 5,623,816 | US$212.02M | 26.55% |
| MEIRAGTX HLDGS PLCCOM | Unchanged | 6,641,064 | US$89.72M | 11.23% |
| RAPPORT THERAPEUTICS INCCOM | Unchanged | 1,784,517 | US$74.36M | 9.31% |
| CTNMCONTINEUM THERAPEUTICS INCCL A | Unchanged | 1,979,173 | US$32.44M | 4.06% |
| LEGNLEGEND BIOTECH CORPSPONSORED ADS | Unchanged | 814,586 | US$23.53M | 2.95% |
| CVRX INCCOM | Unchanged | 4,024,861 | US$20.69M | 2.59% |
| XENCOR INCCOM | Unchanged | 748,062 | US$12.04M | 1.51% |
| CBRSCEREBRAS SYSTEMS INCCOM CL A | New | 53,586 | US$11.84M | 1.48% |
| FATE THERAPEUTICS INCCOM | Unchanged | 3,379,064 | US$9.12M | 1.14% |
Sign in (free) to see its 15 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 6, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.